Numerous studies showed a benefit of prophylactic blockade of C5a or C5aR1 prior to induction of an inflammatory insult in experimental inflammatory bowel disease (62), asthma (30, 63), or sepsis (64, –, 67). Here, C5AR1 is linked to inflammatory bowel disease.